Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
Allergol Immunopathol (Madr)
; 42(3): 245-60, 2014.
Article
em En
| MEDLINE
| ID: mdl-23333411
ABSTRACT
Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Imunização Passiva
/
Imunoglobulinas Intravenosas
/
Síndromes de Imunodeficiência
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article